Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2024 Aug;26(8):3478-3481.
doi: 10.1111/dom.15687. Epub 2024 Jun 5.

Hypoglycaemia and kidney events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: Observations from the VERTIS CV trial

Ayodele Odutayo  1 , Francesco Cosentino  2 , Richard E Pratley  3 , Samuel Dagogo-Jack  4 , Darren K McGuire  5 , Robert Frederich  6 , Wei Fu  7 , Christopher P Cannon  8 , David Z I Cherney  1 ; VERTIS CV Investigators
Affiliations
Randomized Controlled Trial

Hypoglycaemia and kidney events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: Observations from the VERTIS CV trial

Ayodele Odutayo et al. Diabetes Obes Metab. 2024 Aug.
No abstract available

PubMed Disclaimer

References

REFERENCES

    1. U.K. Hypoglycaemia Study Group. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia. 2007;50:1140‐1147.
    1. Gerich JE. Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications. Diabet Med. 2010;27:136‐142.
    1. Koh HE, Cao C, Mittendorfer B. Insulin clearance in obesity and type 2 diabetes. Int J Mol Sci. 2022;23:596.
    1. Cannon CP, McGuire DK, Pratley R, et al. Design and baseline characteristics of the eValuation of ERTugliflozin effIcacy and safety CardioVascular outcomes trial (VERTIS‐CV). Am Heart J. 2018;206:11‐23.
    1. Cannon CP, Pratley R, Dagogo‐Jack S, et al. Cardiovascular outcomes with ertugliflozin in type 2 diabetes. N Engl J Med. 2020;383:1425‐1435.

MeSH terms

Substances

LinkOut - more resources